참고문헌 (37)

1. Trends Mol Med ZS Guo 14 410 2008 10.1016/j.molmed.2008.07.003 Guo ZS, Li Q, Bartlett DL, Yang JY, Fang B . Gene transfer: the challenge of regulated gene expression. Trends Mol Med 2008; 14: 410-418. 

   상세보기

2. Cancer Gene Ther ZR Yang 14 599 2007 10.1038/sj.cgt.7701054 Yang ZR, Wang HF, Zhao J, Peng YY, Wang J, Guinn BA et al. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Cancer Gene Ther 2007; 14: 599-615. 

   상세보기

3. J Gene Med ML Edelstein 6 597 2004 10.1002/jgm.619 Edelstein ML, Abedi MR, Wixon J, Edelstein RM . Gene therapy clinical trials worldwide. J Gene Med 2004; 6: 597-602. 

   상세보기

4. Cancer Res S Ponnazhagan 61 6313 2001 Ponnazhagan S, Curiel DT, Shaw DR, Alvarez RD, Siegal GP . Adeno-associated virus for cancer gene therapy. Cancer Res 2001; 61: 6313-6321. 

   상세보기

5. J Surg Oncol RM Hughes 85 28 2004 10.1002/jso.20001 Hughes RM . Strategies for cancer gene therapy. J Surg Oncol 2004; 85: 28-35. 

   상세보기

6. Nat Med JA Roth 2 985 1996 10.1038/nm0996-985 Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 1996; 2: 985-991. 

   상세보기

7. Hum Gene Ther Z Peng 16 1016 2005 10.1089/hum.2005.16.1016 Peng Z . Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther 2005; 16: 1016-1027. 

   상세보기

8. Neurology J Fueyo 50 1307 1998 10.1212/WNL.50.5.1307 Fueyo J, Gomez-Manzano C, Yung WK, Liu TJ, Alemany R, Bruner JM et al. Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology 1998; 50: 1307-1315. 

   상세보기

9. Cancer Res T Minaguchi 59 6063 1999 Minaguchi T, Mori T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y et al. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene. Cancer Res 1999; 59: 6063-6067. 

   상세보기

10. Mol Cell Biol HS Yang 23 26 2003 10.1128/MCB.23.1.26-37.2003 Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003; 23: 26-37. 

    상세보기

11. Cancer Res AP Jansen 65 6034 2005 10.1158/0008-5472.CAN-04-2119 Jansen AP, Camalier CE, Colburn NH . Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 2005; 65: 6034-6041. 

    상세보기

12. Oncogene Q Wang 27 1527 2008 10.1038/sj.onc.1210793 Wang Q, Sun Z, Yang HS . Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 2008; 27: 1527-1535. 

    상세보기

13. Biol Cell B Lankat-Buttgereit 101 309 2009 10.1042/BC20080191 Lankat-Buttgereit B, Goke R . The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 2009; 101: 309-317. 

    상세보기

14. Oncogene O Afonja 23 8135 2004 10.1038/sj.onc.1207983 Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH . Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 2004; 23: 8135-8145. 

    상세보기

15. Mol Cancer Ther H Jin 5 1041 2006 10.1158/1535-7163.MCT-05-0433 Jin H, Kim TH, Hwang SK, Chang SH, Kim HW, Anderson HK et al. Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther 2006; 5: 1041-1049. 

    상세보기

16. J Biotechnol YK Kim 131 353 2007 10.1016/j.jbiotec.2007.07.938 Kim YK, Choi JY, Yoo MK, Jiang HL, Arote R, Je YH et al. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro. J Biotechnol 2007; 131: 353-361. 

    상세보기

17. J Biotechnol YK Kim 125 104 2006 10.1016/j.jbiotec.2006.02.015 Kim YK, Park IK, Jiang HL, Choi JY, Je YH, Jin H et al. Regulation of transduction efficiency by pegylation of baculovirus vector in vitro and in vivo. J Biotechnol 2006; 125: 104-109. 

    상세보기

18. Pharm Res XQ Pan 20 417 2003 10.1023/A:1022656105022 Pan XQ, Wang H, Lee RJ . Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res 2003; 20: 417-422. 

    상세보기

19. Annu Rev Microbiol AE Smith 49 807 1995 10.1146/annurev.mi.49.100195.004111 Smith AE . Viral vectors in gene therapy. Annu Rev Microbiol 1995; 49: 807-838. 

    상세보기

20. Curr Gene Ther Q Wu 1 101 2001 10.2174/1566523013349002 Wu Q, Moyana T, Xiang J . Cancer gene therapy by adenovirus-mediated gene transfer. Curr Gene Ther 2001; 1: 101-122. 

    

21. Nat Med MA Kay 7 33 2001 10.1038/83324 Kay MA, Glorioso JC, Naldini L . Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40. 

    상세보기

22. Gene Ther AR Frampton Jr 12 891 2005 10.1038/sj.gt.3302545 Frampton Jr AR, Goins WF, Nakano K, Burton EA, Glorioso JC . HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther 2005; 12: 891-901. 

    상세보기

23. Mol Biotechnol JT Douglas 36 71 2007 10.1007/s12033-007-0021-5 Douglas JT . Adenoviral vectors for gene therapy. Mol Biotechnol 2007; 36: 71-80. 

    상세보기

24. J Virol H Tani 77 9799 2003 10.1128/JVI.77.18.9799-9808.2003 Tani H, Limn CK, Yap CC, Onishi M, Nozaki M, Nishimune Y et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003; 77: 9799-9808. 

    상세보기

25. Adv Virus Res YC Hu 68 287 2006 10.1016/S0065-3527(06)68008-1 Hu YC . Baculovirus vectors for gene therapy. Adv Virus Res 2006; 68: 287-320. 

    상세보기

26. AAPS J S Boeckle 8 E731 2006 10.1208/aapsj080483 Boeckle S, Wagner E . Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J 2006; 8: E731-E742. 

    상세보기

27. Macromol Biosci KC Cho 5 512 2005 10.1002/mabi.200500018 Cho KC, Kim SH, Jeong JH, Park TG . Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. Macromol Biosci 2005; 5: 512-519. 

    상세보기

28. Bioconjug Chem CP Leamon 14 738 2003 10.1021/bc020089t Leamon CP, Cooper SR, Hardee GE . Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo. Bioconjug Chem 2003; 14: 738-747. 

    상세보기

29. J Virol AR Makela 80 6603 2006 10.1128/JVI.00528-06 Makela AR, Matilainen H, White DJ, Ruoslahti E, Oker-Blom C . Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides. J Virol 2006; 80: 6603-6611. 

    상세보기

30. J Virol ND van Loo 75 961 2001 10.1128/JVI.75.2.961-970.2001 van Loo ND, Fortunati E, Ehlert E, Rabelink M, Grosveld F, Scholte BJ . Baculovirus infection of non-dividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J Virol 2001; 75: 961-970. 

    상세보기

31. Cancer Lett T Kniazhanski 271 34 2008 10.1016/j.canlet.2008.05.031 Kniazhanski T, Jackman A, Heyfets A, Gonen P, Flescher E, Sherman L . Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells. Cancer Lett 2008; 271: 34-46. 

    상세보기

32. Science JM Adams 281 1322 1998 10.1126/science.281.5381.1322 Adams JM, Cory S . The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1326. 

    상세보기

33. Cancer Res CP Leamon 68 9839 2008 10.1158/0008-5472.CAN-08-2341 Leamon CP, Reddy JA, Vetzel M, Dorton R, Westrick E, Parker N et al. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue. Cancer Res 2008; 68: 9839-9844. 

    상세보기

34. Proc Natl Acad Sci USA JP Condreay 96 127 1999 10.1073/pnas.96.1.127 Condreay JP, Witherspoon SM, Clay WC, Kost TA . Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999; 96: 127-132. 

    상세보기

35. Cancer Lett S Singh 236 213 2006 10.1016/j.canlet.2005.05.024 Singh S, Chhipa RR, Vijayakumar MV, Bhat MK . DNA damaging drugs-induced downregulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells. Cancer Lett 2006; 236: 213-221. 

    상세보기

36. Nat Cell Biol MG Vander Heiden 1 E209 1999 10.1038/70237 Vander Heiden MG, Thompson CB . Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis. Nat Cell Biol 1999; 1: E209-E216. 

    상세보기

37. Mol Immunol C Borner 39 615 2003 10.1016/S0161-5890(02)00252-3 Borner C . The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003; 39: 615-647. 

    상세보기